EPIVIR is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Lamivudine.
| Product ID | 50090-0550_919f0d67-a0da-4ad8-a12a-e0c0922cd4be |
| NDC | 50090-0550 |
| Product Type | Human Prescription Drug |
| Proprietary Name | EPIVIR |
| Generic Name | Lamivudine |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2010-10-04 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020564 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | LAMIVUDINE |
| Active Ingredient Strength | 150 mg/1 |
| Pharm Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2014-11-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020564 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-11-28 |
| Marketing End Date | 2018-10-31 |
| Ingredient | Strength |
|---|---|
| LAMIVUDINE | 150 mg/1 |
| SPL SET ID: | 6f823564-b8db-4f69-8b9a-398c4de4c555 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0173-0662 | EPIVIR | lamivudine |
| 0173-0663 | EPIVIR | lamivudine |
| 21695-367 | EPIVIR | lamivudine |
| 49702-203 | EPIVIR | lamivudine |
| 49702-204 | EPIVIR | lamivudine |
| 49702-205 | EPIVIR | lamivudine |
| 50090-0550 | EPIVIR | lamivudine |
| 53808-0245 | EPIVIR | EPIVIR |
| 53808-0246 | EPIVIR | EPIVIR |
| 0904-6583 | LAMIVUDINE | lamivudine |
| 10135-605 | Lamivudine | Lamivudine |
| 31722-001 | lamivudine | lamivudine |
| 31722-752 | Lamivudine | Lamivudine |
| 31722-753 | Lamivudine | Lamivudine |
| 31722-754 | Lamivudine | Lamivudine |
| 33342-001 | Lamivudine | Lamivudine |
| 33342-002 | Lamivudine | Lamivudine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EPIVIR 78906783 3227835 Live/Registered |
VIIV HEALTHCARE COMPANY 2006-06-13 |
![]() EPIVIR 74213040 1981308 Live/Registered |
VIIV HEALTHCARE COMPANY 1991-10-11 |